Ryan Nicholson - 13 Feb 2026 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Ryan Nicholson
Issuer symbol
DLB
Transactions as of
13 Feb 2026
Net transactions value
-$55,674
Form type
4
Filing time
17 Feb 2026, 17:57:48 UTC
Previous filing
17 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nicholson Ryan VP, CAO and Corp. Controller C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO /s/ Daniel Rodriguez as Attorney-in-Fact for Ryan Nicholson 17 Feb 2026 0001767009

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Options Exercise $121,348 +2,667 +7.2% $45.50 39,623 13 Feb 2026 Direct F1
transaction DLB Class A Common Stock Sale $177,023 -2,667 -6.7% $66.38 36,956 13 Feb 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (Right to Buy) Options Exercise $0 -2,667 -100% $0.000000 0 13 Feb 2026 Class A Common Stock 2,667 $45.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held following the reported transactions include 19,303 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F2 The shares were sold in multiple transactions at prices ranging from $66.37 to $66.39, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 This option was granted for a total of 2,667 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.